• B Beleyn, S Vermeersch, A Kulo, A Smits, R Verbesselt, J N de Hoon, K Van Calsteren, and K Allegaert.
• Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
• Gynecol. Obstet. Invest. 2014 Jan 1; 77 (4): 211-6.

AimParacetamol clearance differs between pregnant and non-pregnant women and between women with or without specific oral contraceptives (OCs). However, an association between female sex hormones and paracetamol clearance has never been explored.MethodsIn total, 49 women at delivery, 8 female control subjects without OC use, historical data of 14 women taking OCs, and 15 postpartum observations with and without OCs were pooled to explore covariates of paracetamol clearance. All received a single intravenous 2-gram paracetamol dose, and blood samples were collected up to 6 h after dosing. High-performance liquid chromatography was used to quantify paracetamol. The area under the curve to time infinity (AUC0-∞) was determined and clearance (l/h·m(2)) was calculated by dose/ AUC0-∞. In addition, estradiol and progesterone were quantified by ELISA with electro-chemiluminescence.ResultsMedian paracetamol clearance at delivery was significantly higher when compared to postpartum or non-pregnant women (11.9 vs. 6.42 and 8.4 l/h·m(2), at least p < 0.05), while an association between paracetamol clearance and estradiol was observed (R = 0.494, p < 0.0001). In non-pregnant subjects, there was no impact of OC exposure on paracetamol clearance. Multiple regression revealed a linear association (Radj = 0.41, p < 0.001) between paracetamol clearance and weight (p = 0.0462) and estradiol (p < 0.0001).ConclusionEstradiol and weight in part explain the variation in paracetamol clearance in young women.© 2014 S. Karger AG, Basel.

30 keywords...

hide…